{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:10:46Z","timestamp":1789726246135,"version":"4.0.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T00:00:00Z","timestamp":1597536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Macrolide antibiotics are among the most commonly used antibiotics; the association of macrolide antibiotics exposure with sensorineural hearing loss (SNHL) has been hypothesized. A systematic search was conducted in PubMed, EMBASE and Cochrane Library from inception to 15 July 2019 to identify studies used macrolide antibiotics for any indication. The results were reported as odds ratio (OR) with 95% confidence interval (CI) using random-effects model to derive the association of macrolide antibiotics exposure with SNHL. The objective of this meta-analysis was to estimate the association of macrolide antibiotics exposure and SNHL from up-to-date evidence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Nine studies met the inclusion criteria. There was no statistically significant association between macrolide antibiotics exposure and SNHL; the OR was 1.20 (95% CI: 0.96 to 1.49). No significant association was found with any of the subgroup meta-analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Whilst the frequency of SNHL was higher with macrolide antibiotics exposure compared with controls, overall, no association was found between macrolide antibiotics and SNHL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/ijpp.12670","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T20:15:35Z","timestamp":1598991335000},"page":"21-28","source":"Crossref","is-referenced-by-count":18,"title":["Sensorineural hearing loss with macrolide antibiotics exposure: a meta-analysis of the association"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0450-9846","authenticated-orcid":false,"given":"Yazed Saleh","family":"Alsowaida","sequence":"first","affiliation":[{"name":"Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA"},{"name":"Department of Pharmacy Services, Brigham and Women\u2019s Hospital, Boston, MA, USA"},{"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3727-7543","authenticated-orcid":false,"given":"Abdulaziz Saleh","family":"Almulhim","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA"},{"name":"College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mok","family":"Oh","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Erstad","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice & Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Abraham","sequence":"additional","affiliation":[{"name":"Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona, Tucson, AZ, USA"},{"name":"University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA"},{"name":"Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA"},{"name":"Department of Family and Community Medicine, College of Medicine \u2013 Tucson, University of Arizona, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,16]]},"reference":[{"key":"2021021707535718000_CIT0001","first-page":"1","article-title":"Centers for Disease Control and Prevention: sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl 2","key":"2021021707535718000_CIT0002","first-page":"S27","article-title":"Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults","volume":"44","author":"Mandell","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021021707535718000_CIT0003","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2021021707535718000_CIT0004","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"2021021707535718000_CIT0005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"2021021707535718000_CIT0006","author":"Committee on Accessible and Affordable Hearing Health Care for Adults","year":"2016"},{"key":"2021021707535718000_CIT0007","author":"Jameson","edition":"20"},{"key":"2021021707535718000_CIT0008","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/geront\/43.5.661","article-title":"The impact of hearing loss on quality of life in older adults","volume":"43","author":"Dalton","year":"2003","journal-title":"Gerontologist"},{"key":"2021021707535718000_CIT0009","doi-asserted-by":"crossref","first-page":"188","DOI":"10.7326\/0003-4819-113-3-188","article-title":"Quality-of-life changes and hearing impairment. A randomized trial","volume":"113","author":"Mulrow","year":"1990","journal-title":"Ann Intern Med"},{"key":"2021021707535718000_CIT0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2310\/7070.2007.0047","article-title":"Sensorineural hearing loss as a probable serious adverse drug reaction associated with low-dose oral azithromycin","volume":"36","author":"Mick","year":"2007","journal-title":"J Otolaryngol"},{"key":"2021021707535718000_CIT0011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(94)91030-8","article-title":"Ototoxicity with azithromycin","volume":"343","author":"Wallace","year":"1994","journal-title":"Lancet"},{"key":"2021021707535718000_CIT0012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/pgmj.2004.020412","article-title":"Irreversible sensorineural hearing loss due to clarithromycin","volume":"81","author":"Coulston","year":"2005","journal-title":"Postgrad Med J"},{"key":"2021021707535718000_CIT0013","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1432-2277.1994.tb01279.x","article-title":"Erythromycin ototoxicity in liver transplant patients","volume":"7","author":"Moral","year":"1994","journal-title":"Transpl Int"},{"key":"2021021707535718000_CIT0014","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/019459988409200615","article-title":"Erythromycin ototoxicity: analysis and conclusions based on 22 case reports","volume":"92","author":"Haydon","year":"1984","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2021021707535718000_CIT0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/000348940010900416","article-title":"Irreversible sensorineural hearing loss as a result of azithromycin ototoxicity. A case report","volume":"109","author":"Ress","year":"2000","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"2021021707535718000_CIT0016","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archotol.1984.00800300050011","article-title":"Ototoxic effect of erythromycin therapy","volume":"110","author":"Schweitzer","year":"1984","journal-title":"Arch Otolaryngol"},{"key":"2021021707535718000_CIT0017","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1592\/phco.19.3.245.30930","article-title":"Intravenous azithromycin-induced ototoxicity","volume":"19","author":"Bizjak","year":"1999","journal-title":"Pharmacotherapy"},{"key":"2021021707535718000_CIT0018","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/lary.26799","article-title":"Macrolide-associated sensorineural hearing loss: a systematic review","volume":"128","author":"Ikeda","year":"2018","journal-title":"Laryngoscope"},{"key":"2021021707535718000_CIT0019","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AAC.02067-13","article-title":"Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases","volume":"58","author":"Li","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2021021707535718000_CIT0020","first-page":"CD011825","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication","author":"Hansen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021021707535718000_CIT0021","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/MAO.0000000000001887","article-title":"Azithromycin and sensorineural hearing loss in adults: a retrospective cohort study","volume":"39","author":"Alrwisan","year":"2018","journal-title":"Otol Neurotol"},{"key":"2021021707535718000_CIT0022","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/lary.26190","article-title":"Risk of sensorineural hearing loss with macrolide antibiotics: a nested case-control study","volume":"127","author":"Etminan","year":"2017","journal-title":"Laryngoscope"},{"key":"2021021707535718000_CIT0023","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2021021707535718000_CIT0024","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2021021707535718000_CIT0025","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2021021707535718000_CIT0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"2021021707535718000_CIT0027","author":"Wells"},{"key":"2021021707535718000_CIT0028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"2021021707535718000_CIT0029","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2021021707535718000_CIT0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/515071","article-title":"Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia","volume":"28","author":"Taylor","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2021021707535718000_CIT0031","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa043526","article-title":"Azithromycin for the secondary prevention of coronary events","volume":"352","author":"Grayston","year":"2005","journal-title":"N Engl J Med"},{"key":"2021021707535718000_CIT0032","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3122\/jabfm.2012.04.110309","article-title":"Azithromycin for bronchial asthma in adults: an effectiveness trial","volume":"25","author":"Hahn","year":"2012","journal-title":"J Am Board Fam Med"},{"key":"2021021707535718000_CIT0033","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"2021021707535718000_CIT0034","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-9343(92)90016-5","article-title":"Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia","volume":"92","author":"Swanson","year":"1992","journal-title":"Am J Med"},{"key":"2021021707535718000_CIT0035","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.1993.00410070063009","article-title":"Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin","volume":"153","author":"Vasquez","year":"1993","journal-title":"Arch Intern Med"},{"key":"2021021707535718000_CIT0036","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/clinids\/24.5.958","article-title":"Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease","volume":"24","author":"Brown","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2021021707535718000_CIT0037","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/clinids\/23.5.983","article-title":"Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus","volume":"23","author":"Griffith","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021021707535718000_CIT0038","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/AAC.47.7.2199-2203.2003","article-title":"Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, Indonesia","volume":"47","author":"Taylor","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijpp.12670","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijpp.12670","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/29\/1\/21\/36290985\/ijpp12670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/29\/1\/21\/36290985\/ijpp12670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T11:31:19Z","timestamp":1613820679000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/29\/1\/21\/6025582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,8,16]]},"published-print":{"date-parts":[[2021,2,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ijpp.12670","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,8,16]]}}}